(c) Women with cytological abnormalities of HSIL or more
| HPV type | 10–19 n = 4 |
20–29 n = 127 |
30–39 n = 183 |
40–49 n = 117 |
50–59 n = 64 |
60–69 n = 41 |
>70 n = 18 |
All n = 554 |
|---|---|---|---|---|---|---|---|---|
| HPV 16 | 1 (25.0%) | 59 (46.5%) | 53 (29.0%) | 36 (30.8%) | 14 (21.9%) | 4 (9.8%) | 3 (16.7%) | 170 (30.7%) |
| HPV 18 | 0 | 5 (3.9%) | 10 (5.5%) | 6 (5.1%) | 5 (7.8%) | 2 (4.9%) | 0 | 28 (5.1%) |
| HPV 52 | 1 (25.0%) | 29 (22.8%) | 42 (23.0%) | 28 (23.9%) | 12 (18.8%) | 13 (31.7%) | 6 (33.3%) | 131 (23.6%) |
| HPV 58 | 1 (25.0%) | 31 (24.4%) | 35 (19.1%) | 17 (14.5%) | 11 (17.2%) | 12 (29.3%) | 2 (11.1%) | 109 (19.7%) |